Zuranolone: A New Dawn for Postpartum Depression Treatment
Apr 1, 2024
12:13
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In this episode, we discuss the groundbreaking FDA approval of zuranolone, the first oral medication specifically targeting postpartum depression. Could zuranolone's novel mechanism of action as an allopregnanolone agonist herald a new era of rapid-onset, targeted treatments for this debilitating condition affecting 1 in 8 new mothers?
Faculty: Vivien Burt, M.D. Host: Richard Seeber, M.D.
Psychopharmacology and Psychiatry Updates